(Q38273780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

review article

1 reference

title

Modern banking, collection, compatibility testing and storage of blood and blood components (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

S Allard

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

R Cardigan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

70 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

3-9, e2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Where are we at with point-of-care testing in haematology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

To filter blood or universal leukoreduction: what is the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

A biochemical comparison of a pharmaceutically licensed coagulation active plasma (Octaplas) with a universally applicable development product (Uniplas) and single-donor FFPs subjected to methylene-blue dye and white-light treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Preclinical safety profile of plasma prepared using the INTERCEPT Blood System

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Requirements for the electronic crossmatch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Setbacks in blood substitutes research and development: a biochemical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Blood substitutes: why haven't we been more successful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

Hemoglobin-based oxygen carriers: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12912

21 January 2018

Identifiers

DOI

10.1111/ANAE.12912

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25440389%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference